Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Jul 30, 2014 brown michael s Director Disposition (Non Open Market) 5,687 n/a
Jul 17, 2014 brown michael s Director Disposition (Non Open Market) 14,662 n/a
Dec 22, 2010 brown michael s Director Disposition (Non Open Market) 5,000 n/a
Jan 2, 2009 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Nov 17, 2009 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Oct 20, 2010 gilman alfred g Director Disposition (Non Open Market) 9,000 n/a
Oct 21, 2010 gilman alfred g Director Disposition (Non Open Market) 1,000 n/a
Dec 23, 2008 gilman alfred g Director Disposition (Non Open Market) 6,000 n/a
Dec 13, 2011 gilman alfred g Director Disposition (Non Open Market) 11,875 n/a
Feb 14, 2012 gilman alfred g Director Disposition (Non Open Market) 3,266 111.01
Dec 21, 2009 gilman alfred g Director Disposition (Non Open Market) 8,000 n/a
May 27, 2010 gilman alfred g Director Disposition (Non Open Market) 4,553 27.92
Dec 19, 2008 gilman alfred g Director Disposition (Non Open Market) 1,000 n/a
Dec 12, 2007 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Dec 17, 2007 gilman alfred g Director Disposition (Non Open Market) 1,500 n/a
Dec 19, 2007 gilman alfred g Director Disposition (Non Open Market) 500 n/a
Dec 24, 2007 gilman alfred g Director Disposition (Non Open Market) 500 n/a
Dec 3, 2012 goldberg murray a Officer Disposition (Non Open Market) 14,500 n/a
Dec 17, 2007 goldberg murray a Officer Disposition (Non Open Market) 200 n/a
Dec 8, 2008 goldberg murray a Officer Disposition (Non Open Market) 120 n/a
Showing 361-380 of 863 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)